An open-label pilot study of transdermal methylphenidate in children with autism spectrum disorders, Inattention, Hyperactivity, and Impulsivity
Product/Publication Type(s):
Conference presentations and posters presented
Target Audience:
Consumers/Families, Professionals, Students
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A